The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
Open Access
- 26 September 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (9) , e38046
Abstract
The SARI (suppressor of AP-1, regulated by IFN) gene, which is also called BATF2, is associated with the risk of several kinds of cancer, and loss of SARI expression is frequently detected in aggressive and metastatic cancer. However, the functional role of SARI in lung adenocarcinoma remains unknown. We have shown that loss of SARI expression initiates epithelial-mesenchymal transition (EMT), which is visualized by repression of E-cadherin and up-regulation of vimentin in lung adenocarcinoma cell lines and in clinical lung adenocarcinoma specimens. Using a human lung xenograft-mouse model, we observed that knocking down endogenous SARI in human carcinoma cells leads to the development of multiple lymph node metastases. Moreover, we showed that SARI functions as a critical protein in regulating EMT by modulating the (GSK)-3β-β-catenin signaling pathway. These results demonstrate the mechanism of SARI function in EMT and suggest that assessment of SARI may serve as a prognostic biomarker and potential therapeutic target for lung adenocarcinoma metastasis.Keywords
This publication has 33 references indexed in Scilit:
- Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selectionLung Cancer, 2011
- Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like charactersBMC Cancer, 2011
- Stage-specific sensitivity to p53 restoration during lung cancer progressionNature, 2010
- Annexin A1 attenuates EMT and metastatic potential in breast cancerEMBO Molecular Medicine, 2010
- TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinomaOncogene, 2010
- SLIT2 Attenuation during Lung Cancer Progression Deregulates β-Catenin and E-Cadherin and Associates with Poor PrognosisCancer Research, 2010
- Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN)Proceedings of the National Academy of Sciences, 2008
- Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-CateninMolecular Cell, 2005
- Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysisThe EMBO Journal, 2005
- Geometrical isomers of ()- and ()-neoxanthin and biological implicationsBiochemical Systematics and Ecology, 2000